搜索筛选:
搜索耗时0.0965秒,为你在为你在102,285,761篇论文里面共找到 10 篇相符的论文内容
类      型:
[期刊论文] 作者:Xia Liu,Li Ma,Jinhui Tian,Kehu, 来源:临床肿瘤与癌症研究:英文版 年份:2009
OBJECTIVE To evaluate the efficacy and adverse effects ofgemcitabine versus pegylated liposomal doxorubicin in patientswith progressive or recurrent ovaria...
[期刊论文] 作者:Xia Liu,Li Ma,Jinhui Tian,Kehu, 来源:临床肿瘤与癌症研究(英文版) 年份:2004
OBJECTIVE To evaluate the efficacy and adverse effects of gemcitabine versus pegylated liposomal doxorubicin in patients with progressive or recurrent ovarian c...
[期刊论文] 作者:Xia Liu,Li Ma,Jinhui Tian,Kehu, 来源:癌症生物学与医学(英文版) 年份:2009
[期刊论文] 作者:CAI Kailin,Chen Daoda,WANG Guobin,LU Xiaoming,ZHANG Jinhui,TIAN Yuan, 来源:华中科技大学学报(医学英德文版) 年份:2001
To investigate the correlation between the activity of kinases in the growth factor signal transduction pathway and the development of resistance of breast canc...
[会议论文] 作者:Jinhui Tian,Qinning Zhang,Ruifeng Liu,Juntao Ran,Hongtao Luo,Xiaohu Wang,Qingfagn Lv, 来源:中华医学会第十二次全国放射肿瘤学治疗学学术会议 年份:2015
[会议论文] 作者:qiuning zhang,Xiaohu Wang,Jinhui Tian,Hongtao Luo,Juntao Ran,Ruifeng Liu,Qingfang Lv, 来源:中华医学会第十二次全国放射肿瘤学治疗学学术会议 年份:2015
[会议论文] 作者:qiuning zhang,Jinhui Tian,Xiaohu Wang,Juntao Ran,Ruifeng Liu,Hongtao Luo,Qingfang Lv, 来源:中华医学会第十二次全国放射肿瘤学治疗学学术会议 年份:2015
Purpose To synthesize and compare available evidence considering the effectiveness of carbon-ion radiotherapy for stage Ⅰ non-small cell lung cancer.Methods A comprehensive search was conducted in the...
[会议论文] 作者:Jinhui Tian,Qinning Zhang,Xiaohu Wang,Juntao Ran,Ruifeng Liu,Hongtao Luo,Qingfagn Lv, 来源:中华医学会第十二次全国放射肿瘤学治疗学学术会议 年份:2015
Purpose To synthesize and compare available evidence to compare the Long-Term clinical outcomes of proton therapy (PT) with those of carbon ion therapy (CIT) for stage Ⅰ non-small cell lung cancer (NS...
[会议论文] 作者:Lun Li,Yonghui Su,Bingqiu Xiu,Xiaoyan Huang,Jianjing Hou,Weiru Chi,Yingying Zhang,Jinhui Tian,Jia Wang, 来源:2019中国肿瘤学大会 年份:2019
[期刊论文] 作者:Jiang Li,Jianguo Xu,Yadi Zheng,Ya Gao,Siyi He,He Li,Kaiyong Zou,Ni Li,Jinhui Tian,Wanqing Chen,Jie He, 来源:中国癌症研究(英文版) 年份:2021
More than 600,000 people are diagnosed with esophageal cancer (EC) every year globally,and the five-year survival rate of EC is less than 20%.Two common histological subtypes of EC,esophageal squamous cell carcinoma(ESCC) and esophageal aden......
相关搜索: